Go backIncome
Assets
Liabilities
Other
UAB "Novo Nordisk Pharma"
Novo Nordisk Pharma
is not in process of liquidation on May 1, 2024
To view all financial indicators, unlock this company.
Income
Financial indicator20212020
Net sales
14.3M EUR
17%
12.1M EUR
7%
Net profit
313K EUR
14%
274K EUR
9%
Profit before tax
░░░░░░░░
0%
░░░░░░░░
0%
Assets
Financial indicator20212020
Fixed assets
22.1K EUR
-11%
24.6K EUR
32%
Current assets
░░░░░░░░
0%
░░░░░░░░
0%
Equity
░░░░░░░░
0%
░░░░░░░░
0%
Liabilities
Financial indicator20212020
Payables and liabilities
░░░░░░░░
0%
░░░░░░░░
0%
Your trusted source for business data
Socials
English, USA
English, USA